nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitisinone—HPD—Phenylalanine and tyrosine catabolism—CCBL1—kidney cancer	0.205	0.692	CbGpPWpGaD
Nitisinone—HPD—nephron tubule—kidney cancer	0.0536	0.224	CbGeAlD
Nitisinone—HPD—renal system—kidney cancer	0.0487	0.204	CbGeAlD
Nitisinone—HPD—kidney—kidney cancer	0.0471	0.197	CbGeAlD
Nitisinone—HPD—cortex of kidney—kidney cancer	0.0459	0.192	CbGeAlD
Nitisinone—HPD—gonad—kidney cancer	0.0437	0.183	CbGeAlD
Nitisinone—HPD—Amino acid and derivative metabolism—CCBL1—kidney cancer	0.018	0.0608	CbGpPWpGaD
Nitisinone—HPD—Amino acid and derivative metabolism—PSMD7—kidney cancer	0.00666	0.0225	CbGpPWpGaD
Nitisinone—HPD—Amino acid and derivative metabolism—SLC5A5—kidney cancer	0.00623	0.0211	CbGpPWpGaD
Nitisinone—Flutamide—CYP1A1—kidney cancer	0.00494	1	CrCbGaD
Nitisinone—HPD—Metabolism—ACY1—kidney cancer	0.00413	0.014	CbGpPWpGaD
Nitisinone—HPD—Metabolism—PDHB—kidney cancer	0.00351	0.0119	CbGpPWpGaD
Nitisinone—HPD—Metabolism—CCBL1—kidney cancer	0.0033	0.0112	CbGpPWpGaD
Nitisinone—HPD—Metabolism—GLIPR1—kidney cancer	0.00286	0.00968	CbGpPWpGaD
Nitisinone—HPD—Metabolism—PPAT—kidney cancer	0.00286	0.00968	CbGpPWpGaD
Nitisinone—HPD—Metabolism—APRT—kidney cancer	0.00266	0.009	CbGpPWpGaD
Nitisinone—HPD—Metabolism—FH—kidney cancer	0.00266	0.009	CbGpPWpGaD
Nitisinone—HPD—Metabolism—GPC3—kidney cancer	0.0025	0.00846	CbGpPWpGaD
Nitisinone—HPD—Metabolism—CA2—kidney cancer	0.00243	0.00823	CbGpPWpGaD
Nitisinone—HPD—Metabolism—ALAD—kidney cancer	0.00237	0.00802	CbGpPWpGaD
Nitisinone—HPD—Metabolism—ST3GAL2—kidney cancer	0.00232	0.00783	CbGpPWpGaD
Nitisinone—HPD—Metabolism—ALDH1A1—kidney cancer	0.00226	0.00765	CbGpPWpGaD
Nitisinone—HPD—Metabolism—PGK1—kidney cancer	0.00217	0.00734	CbGpPWpGaD
Nitisinone—HPD—Metabolism—SLC5A3—kidney cancer	0.00217	0.00734	CbGpPWpGaD
Nitisinone—HPD—Metabolism—LDHB—kidney cancer	0.00213	0.0072	CbGpPWpGaD
Nitisinone—Haemorrhage—Pazopanib—kidney cancer	0.00207	0.00449	CcSEcCtD
Nitisinone—Eye disorder—Temsirolimus—kidney cancer	0.00205	0.00446	CcSEcCtD
Nitisinone—Hypoglycaemia—Sunitinib—kidney cancer	0.00202	0.00439	CcSEcCtD
Nitisinone—Gastritis—Erlotinib—kidney cancer	0.00201	0.00438	CcSEcCtD
Nitisinone—Bronchitis—Everolimus—kidney cancer	0.00196	0.00426	CcSEcCtD
Nitisinone—Rash erythematous—Capecitabine—kidney cancer	0.00195	0.00425	CcSEcCtD
Nitisinone—Eye disorder—Pazopanib—kidney cancer	0.00193	0.0042	CcSEcCtD
Nitisinone—Dehydration—Sorafenib—kidney cancer	0.0019	0.00414	CcSEcCtD
Nitisinone—Sepsis—Gemcitabine—kidney cancer	0.00189	0.00411	CcSEcCtD
Nitisinone—Dry skin—Sorafenib—kidney cancer	0.00188	0.00408	CcSEcCtD
Nitisinone—Respiratory failure—Paclitaxel—kidney cancer	0.00186	0.00404	CcSEcCtD
Nitisinone—Hepatic failure—Vincristine—kidney cancer	0.00186	0.00403	CcSEcCtD
Nitisinone—HPD—Metabolism—CA9—kidney cancer	0.00185	0.00624	CbGpPWpGaD
Nitisinone—Dehydration—Sunitinib—kidney cancer	0.00183	0.00398	CcSEcCtD
Nitisinone—Alopecia—Pazopanib—kidney cancer	0.00183	0.00397	CcSEcCtD
Nitisinone—Gastritis—Sorafenib—kidney cancer	0.00181	0.00394	CcSEcCtD
Nitisinone—Hepatic function abnormal—Gemcitabine—kidney cancer	0.00181	0.00393	CcSEcCtD
Nitisinone—Dry skin—Sunitinib—kidney cancer	0.00181	0.00393	CcSEcCtD
Nitisinone—Melaena—Paclitaxel—kidney cancer	0.00178	0.00387	CcSEcCtD
Nitisinone—Conjunctivitis—Everolimus—kidney cancer	0.00177	0.00384	CcSEcCtD
Nitisinone—Hepatic failure—Gemcitabine—kidney cancer	0.00176	0.00382	CcSEcCtD
Nitisinone—Epistaxis—Everolimus—kidney cancer	0.00172	0.00373	CcSEcCtD
Nitisinone—Leukopenia—Temsirolimus—kidney cancer	0.00171	0.00372	CcSEcCtD
Nitisinone—Conjunctivitis—Erlotinib—kidney cancer	0.00171	0.00371	CcSEcCtD
Nitisinone—Agranulocytosis—Vinblastine—kidney cancer	0.0017	0.0037	CcSEcCtD
Nitisinone—Rash maculo-papular—Paclitaxel—kidney cancer	0.00166	0.0036	CcSEcCtD
Nitisinone—Convulsion—Temsirolimus—kidney cancer	0.00166	0.0036	CcSEcCtD
Nitisinone—Epistaxis—Erlotinib—kidney cancer	0.00165	0.0036	CcSEcCtD
Nitisinone—Haemoglobin—Vinblastine—kidney cancer	0.00165	0.00358	CcSEcCtD
Nitisinone—Haemoglobin—Everolimus—kidney cancer	0.00164	0.00356	CcSEcCtD
Nitisinone—Haemorrhage—Vinblastine—kidney cancer	0.00164	0.00356	CcSEcCtD
Nitisinone—Bronchitis—Sunitinib—kidney cancer	0.00164	0.00356	CcSEcCtD
Nitisinone—Haemorrhage—Everolimus—kidney cancer	0.00163	0.00355	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Temsirolimus—kidney cancer	0.00162	0.00351	CcSEcCtD
Nitisinone—Leukopenia—Pazopanib—kidney cancer	0.00161	0.0035	CcSEcCtD
Nitisinone—Haemoglobin—Erlotinib—kidney cancer	0.00158	0.00344	CcSEcCtD
Nitisinone—Sepsis—Paclitaxel—kidney cancer	0.00158	0.00344	CcSEcCtD
Nitisinone—Haemorrhage—Erlotinib—kidney cancer	0.00158	0.00342	CcSEcCtD
Nitisinone—Cataract—Capecitabine—kidney cancer	0.00157	0.00342	CcSEcCtD
Nitisinone—HPD—Metabolism—CRABP1—kidney cancer	0.00157	0.00531	CbGpPWpGaD
Nitisinone—Dehydration—Vincristine—kidney cancer	0.00155	0.00337	CcSEcCtD
Nitisinone—Infection—Temsirolimus—kidney cancer	0.00155	0.00337	CcSEcCtD
Nitisinone—Thrombocytopenia—Temsirolimus—kidney cancer	0.00153	0.00332	CcSEcCtD
Nitisinone—Eye disorder—Everolimus—kidney cancer	0.00153	0.00331	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Pazopanib—kidney cancer	0.00152	0.00331	CcSEcCtD
Nitisinone—Skin disorder—Temsirolimus—kidney cancer	0.00151	0.00329	CcSEcCtD
Nitisinone—Epistaxis—Sorafenib—kidney cancer	0.00149	0.00323	CcSEcCtD
Nitisinone—Keratitis—Doxorubicin—kidney cancer	0.00149	0.00323	CcSEcCtD
Nitisinone—Eye disorder—Erlotinib—kidney cancer	0.00147	0.0032	CcSEcCtD
Nitisinone—Eye pain—Paclitaxel—kidney cancer	0.00147	0.00319	CcSEcCtD
Nitisinone—Melaena—Capecitabine—kidney cancer	0.00146	0.00318	CcSEcCtD
Nitisinone—Infection—Pazopanib—kidney cancer	0.00146	0.00317	CcSEcCtD
Nitisinone—HPD—Metabolism—ITPR2—kidney cancer	0.00146	0.00493	CbGpPWpGaD
Nitisinone—Alopecia—Vinblastine—kidney cancer	0.00145	0.00315	CcSEcCtD
Nitisinone—Alopecia—Everolimus—kidney cancer	0.00144	0.00313	CcSEcCtD
Nitisinone—Thrombocytopenia—Pazopanib—kidney cancer	0.00144	0.00312	CcSEcCtD
Nitisinone—Epistaxis—Sunitinib—kidney cancer	0.00143	0.00311	CcSEcCtD
Nitisinone—Skin disorder—Pazopanib—kidney cancer	0.00143	0.0031	CcSEcCtD
Nitisinone—Haemoglobin—Sorafenib—kidney cancer	0.00142	0.00309	CcSEcCtD
Nitisinone—Haemorrhage—Sorafenib—kidney cancer	0.00142	0.00308	CcSEcCtD
Nitisinone—Dermatitis exfoliative—Paclitaxel—kidney cancer	0.0014	0.00305	CcSEcCtD
Nitisinone—Alopecia—Erlotinib—kidney cancer	0.00139	0.00302	CcSEcCtD
Nitisinone—Somnolence—Temsirolimus—kidney cancer	0.00139	0.00301	CcSEcCtD
Nitisinone—Haemoglobin—Sunitinib—kidney cancer	0.00137	0.00298	CcSEcCtD
Nitisinone—Haemorrhage—Sunitinib—kidney cancer	0.00136	0.00296	CcSEcCtD
Nitisinone—Hepatomegaly—Doxorubicin—kidney cancer	0.00136	0.00296	CcSEcCtD
Nitisinone—Hypoglycaemia—Paclitaxel—kidney cancer	0.00136	0.00295	CcSEcCtD
Nitisinone—Agranulocytosis—Dactinomycin—kidney cancer	0.00134	0.00292	CcSEcCtD
Nitisinone—HPD—Metabolism—GSTT1—kidney cancer	0.00133	0.0045	CbGpPWpGaD
Nitisinone—HPD—Metabolism—ACHE—kidney cancer	0.00133	0.0045	CbGpPWpGaD
Nitisinone—Agitation—Everolimus—kidney cancer	0.00131	0.00284	CcSEcCtD
Nitisinone—Somnolence—Pazopanib—kidney cancer	0.00131	0.00284	CcSEcCtD
Nitisinone—Sepsis—Capecitabine—kidney cancer	0.0013	0.00282	CcSEcCtD
Nitisinone—Leukopenia—Vinblastine—kidney cancer	0.00128	0.00277	CcSEcCtD
Nitisinone—Gastrointestinal pain—Temsirolimus—kidney cancer	0.00127	0.00277	CcSEcCtD
Nitisinone—Eye disorder—Sunitinib—kidney cancer	0.00127	0.00277	CcSEcCtD
Nitisinone—Leukopenia—Everolimus—kidney cancer	0.00127	0.00276	CcSEcCtD
Nitisinone—Rash erythematous—Doxorubicin—kidney cancer	0.00126	0.00274	CcSEcCtD
Nitisinone—HPD—Metabolism—SCARB1—kidney cancer	0.00126	0.00426	CbGpPWpGaD
Nitisinone—Alopecia—Sorafenib—kidney cancer	0.00125	0.00272	CcSEcCtD
Nitisinone—HPD—Metabolism—PTGS1—kidney cancer	0.00125	0.00422	CbGpPWpGaD
Nitisinone—Hepatic function abnormal—Capecitabine—kidney cancer	0.00124	0.0027	CcSEcCtD
Nitisinone—Convulsion—Vinblastine—kidney cancer	0.00124	0.00269	CcSEcCtD
Nitisinone—Abdominal pain—Temsirolimus—kidney cancer	0.00123	0.00268	CcSEcCtD
Nitisinone—Dehydration—Paclitaxel—kidney cancer	0.00123	0.00268	CcSEcCtD
Nitisinone—Convulsion—Everolimus—kidney cancer	0.00123	0.00268	CcSEcCtD
Nitisinone—Gastroenteritis—Capecitabine—kidney cancer	0.00123	0.00266	CcSEcCtD
Nitisinone—HPD—Metabolism—PSMD7—kidney cancer	0.00122	0.00413	CbGpPWpGaD
Nitisinone—Dry skin—Paclitaxel—kidney cancer	0.00121	0.00264	CcSEcCtD
Nitisinone—Hepatic failure—Capecitabine—kidney cancer	0.00121	0.00263	CcSEcCtD
Nitisinone—Alopecia—Sunitinib—kidney cancer	0.0012	0.00262	CcSEcCtD
Nitisinone—Eye pain—Capecitabine—kidney cancer	0.0012	0.00262	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Everolimus—kidney cancer	0.0012	0.00261	CcSEcCtD
Nitisinone—Gastrointestinal pain—Pazopanib—kidney cancer	0.0012	0.00261	CcSEcCtD
Nitisinone—Abdominal pain—Pazopanib—kidney cancer	0.00116	0.00252	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—kidney cancer	0.00116	0.00252	CcSEcCtD
Nitisinone—HPD—Metabolism—BCHE—kidney cancer	0.00116	0.00392	CbGpPWpGaD
Nitisinone—Infection—Everolimus—kidney cancer	0.00115	0.0025	CcSEcCtD
Nitisinone—Dermatitis exfoliative—Capecitabine—kidney cancer	0.00115	0.0025	CcSEcCtD
Nitisinone—HPD—Metabolism—SLC5A5—kidney cancer	0.00114	0.00387	CbGpPWpGaD
Nitisinone—Thirst—Capecitabine—kidney cancer	0.00114	0.00248	CcSEcCtD
Nitisinone—Alopecia—Dactinomycin—kidney cancer	0.00114	0.00248	CcSEcCtD
Nitisinone—Thrombocytopenia—Vinblastine—kidney cancer	0.00114	0.00248	CcSEcCtD
Nitisinone—Agranulocytosis—Gemcitabine—kidney cancer	0.00114	0.00247	CcSEcCtD
Nitisinone—Thrombocytopenia—Everolimus—kidney cancer	0.00114	0.00247	CcSEcCtD
Nitisinone—Neoplasm malignant—Doxorubicin—kidney cancer	0.00113	0.00246	CcSEcCtD
Nitisinone—Skin disorder—Everolimus—kidney cancer	0.00113	0.00245	CcSEcCtD
Nitisinone—Infection—Erlotinib—kidney cancer	0.00111	0.00242	CcSEcCtD
Nitisinone—HPD—Metabolism—SLC2A1—kidney cancer	0.00111	0.00374	CbGpPWpGaD
Nitisinone—Leukopenia—Sorafenib—kidney cancer	0.0011	0.0024	CcSEcCtD
Nitisinone—Pruritus—Temsirolimus—kidney cancer	0.0011	0.0024	CcSEcCtD
Nitisinone—Bronchitis—Paclitaxel—kidney cancer	0.0011	0.00239	CcSEcCtD
Nitisinone—Haemoglobin—Gemcitabine—kidney cancer	0.0011	0.00239	CcSEcCtD
Nitisinone—Amenorrhoea—Doxorubicin—kidney cancer	0.0011	0.00239	CcSEcCtD
Nitisinone—Thrombocytopenia—Erlotinib—kidney cancer	0.0011	0.00238	CcSEcCtD
Nitisinone—Haemorrhage—Gemcitabine—kidney cancer	0.00109	0.00238	CcSEcCtD
Nitisinone—Skin disorder—Erlotinib—kidney cancer	0.00109	0.00236	CcSEcCtD
Nitisinone—Gastrointestinal haemorrhage—Capecitabine—kidney cancer	0.00109	0.00236	CcSEcCtD
Nitisinone—Diarrhoea—Temsirolimus—kidney cancer	0.00107	0.00232	CcSEcCtD
Nitisinone—Leukopenia—Sunitinib—kidney cancer	0.00106	0.00231	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—kidney cancer	0.00104	0.00227	CcSEcCtD
Nitisinone—Pruritus—Pazopanib—kidney cancer	0.00104	0.00226	CcSEcCtD
Nitisinone—Somnolence—Everolimus—kidney cancer	0.00103	0.00224	CcSEcCtD
Nitisinone—Convulsion—Sunitinib—kidney cancer	0.00103	0.00223	CcSEcCtD
Nitisinone—Alopecia—Vincristine—kidney cancer	0.00102	0.00221	CcSEcCtD
Nitisinone—Dehydration—Capecitabine—kidney cancer	0.00101	0.0022	CcSEcCtD
Nitisinone—Leukopenia—Dactinomycin—kidney cancer	0.00101	0.00219	CcSEcCtD
Nitisinone—Diarrhoea—Pazopanib—kidney cancer	0.00101	0.00218	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—kidney cancer	0.001	0.00218	CcSEcCtD
Nitisinone—Infection—Sorafenib—kidney cancer	0.001	0.00217	CcSEcCtD
Nitisinone—Dry skin—Capecitabine—kidney cancer	0.000996	0.00216	CcSEcCtD
Nitisinone—Conjunctivitis—Paclitaxel—kidney cancer	0.000992	0.00215	CcSEcCtD
Nitisinone—Thrombocytopenia—Sorafenib—kidney cancer	0.000986	0.00214	CcSEcCtD
Nitisinone—Skin disorder—Sorafenib—kidney cancer	0.000978	0.00212	CcSEcCtD
Nitisinone—Headache—Temsirolimus—kidney cancer	0.000977	0.00212	CcSEcCtD
Nitisinone—Alopecia—Gemcitabine—kidney cancer	0.000967	0.0021	CcSEcCtD
Nitisinone—Epistaxis—Paclitaxel—kidney cancer	0.000962	0.00209	CcSEcCtD
Nitisinone—Infection—Sunitinib—kidney cancer	0.000962	0.00209	CcSEcCtD
Nitisinone—Gastritis—Capecitabine—kidney cancer	0.000962	0.00209	CcSEcCtD
Nitisinone—Gastrointestinal pain—Vinblastine—kidney cancer	0.000952	0.00207	CcSEcCtD
Nitisinone—Thrombocytopenia—Sunitinib—kidney cancer	0.000948	0.00206	CcSEcCtD
Nitisinone—Gastrointestinal pain—Everolimus—kidney cancer	0.000948	0.00206	CcSEcCtD
Nitisinone—Melaena—Doxorubicin—kidney cancer	0.000943	0.00205	CcSEcCtD
Nitisinone—Skin disorder—Sunitinib—kidney cancer	0.000941	0.00204	CcSEcCtD
Nitisinone—Agitation—Vincristine—kidney cancer	0.000923	0.002	CcSEcCtD
Nitisinone—HPD—Metabolism—GSTP1—kidney cancer	0.000922	0.00312	CbGpPWpGaD
Nitisinone—Haemoglobin—Paclitaxel—kidney cancer	0.000921	0.002	CcSEcCtD
Nitisinone—Abdominal pain—Vinblastine—kidney cancer	0.00092	0.002	CcSEcCtD
Nitisinone—Headache—Pazopanib—kidney cancer	0.00092	0.002	CcSEcCtD
Nitisinone—Abdominal pain—Everolimus—kidney cancer	0.000917	0.00199	CcSEcCtD
Nitisinone—Haemorrhage—Paclitaxel—kidney cancer	0.000916	0.00199	CcSEcCtD
Nitisinone—Gastrointestinal pain—Erlotinib—kidney cancer	0.000915	0.00199	CcSEcCtD
Nitisinone—Infection—Dactinomycin—kidney cancer	0.000911	0.00198	CcSEcCtD
Nitisinone—Bronchitis—Capecitabine—kidney cancer	0.000903	0.00196	CcSEcCtD
Nitisinone—Leukopenia—Vincristine—kidney cancer	0.000899	0.00195	CcSEcCtD
Nitisinone—Thrombocytopenia—Dactinomycin—kidney cancer	0.000898	0.00195	CcSEcCtD
Nitisinone—Abdominal pain—Erlotinib—kidney cancer	0.000885	0.00192	CcSEcCtD
Nitisinone—Rash maculo-papular—Doxorubicin—kidney cancer	0.000877	0.00191	CcSEcCtD
Nitisinone—HPD—Metabolism—ABCB1—kidney cancer	0.000873	0.00295	CbGpPWpGaD
Nitisinone—Convulsion—Vincristine—kidney cancer	0.00087	0.00189	CcSEcCtD
Nitisinone—Eye disorder—Paclitaxel—kidney cancer	0.000856	0.00186	CcSEcCtD
Nitisinone—Leukopenia—Gemcitabine—kidney cancer	0.000853	0.00185	CcSEcCtD
Nitisinone—HPD—Metabolism—GSTM1—kidney cancer	0.000847	0.00287	CbGpPWpGaD
Nitisinone—Sepsis—Doxorubicin—kidney cancer	0.000837	0.00182	CcSEcCtD
Nitisinone—Gastrointestinal pain—Sorafenib—kidney cancer	0.000823	0.00179	CcSEcCtD
Nitisinone—Pruritus—Everolimus—kidney cancer	0.000821	0.00178	CcSEcCtD
Nitisinone—Infection—Vincristine—kidney cancer	0.000814	0.00177	CcSEcCtD
Nitisinone—Conjunctivitis—Capecitabine—kidney cancer	0.000814	0.00177	CcSEcCtD
Nitisinone—Alopecia—Paclitaxel—kidney cancer	0.000809	0.00176	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000805	0.00175	CcSEcCtD
Nitisinone—HPD—Metabolism—CYP1A1—kidney cancer	0.000803	0.00272	CbGpPWpGaD
Nitisinone—Thrombocytopenia—Vincristine—kidney cancer	0.000802	0.00174	CcSEcCtD
Nitisinone—Hepatic function abnormal—Doxorubicin—kidney cancer	0.000801	0.00174	CcSEcCtD
Nitisinone—Diarrhoea—Vinblastine—kidney cancer	0.000797	0.00173	CcSEcCtD
Nitisinone—Abdominal pain—Sorafenib—kidney cancer	0.000796	0.00173	CcSEcCtD
Nitisinone—Diarrhoea—Everolimus—kidney cancer	0.000794	0.00172	CcSEcCtD
Nitisinone—Gastrointestinal pain—Sunitinib—kidney cancer	0.000792	0.00172	CcSEcCtD
Nitisinone—Pruritus—Erlotinib—kidney cancer	0.000792	0.00172	CcSEcCtD
Nitisinone—Epistaxis—Capecitabine—kidney cancer	0.00079	0.00172	CcSEcCtD
Nitisinone—Tension—Paclitaxel—kidney cancer	0.000782	0.0017	CcSEcCtD
Nitisinone—Agranulocytosis—Capecitabine—kidney cancer	0.000781	0.0017	CcSEcCtD
Nitisinone—Hepatic failure—Doxorubicin—kidney cancer	0.000779	0.00169	CcSEcCtD
Nitisinone—Eye pain—Doxorubicin—kidney cancer	0.000776	0.00169	CcSEcCtD
Nitisinone—Nervousness—Paclitaxel—kidney cancer	0.000774	0.00168	CcSEcCtD
Nitisinone—Infection—Gemcitabine—kidney cancer	0.000772	0.00168	CcSEcCtD
Nitisinone—Abdominal pain—Sunitinib—kidney cancer	0.000766	0.00166	CcSEcCtD
Nitisinone—Diarrhoea—Erlotinib—kidney cancer	0.000766	0.00166	CcSEcCtD
Nitisinone—Thrombocytopenia—Gemcitabine—kidney cancer	0.000761	0.00165	CcSEcCtD
Nitisinone—Haemoglobin—Capecitabine—kidney cancer	0.000756	0.00164	CcSEcCtD
Nitisinone—Skin disorder—Gemcitabine—kidney cancer	0.000755	0.00164	CcSEcCtD
Nitisinone—Haemorrhage—Capecitabine—kidney cancer	0.000752	0.00163	CcSEcCtD
Nitisinone—Gastrointestinal pain—Dactinomycin—kidney cancer	0.00075	0.00163	CcSEcCtD
Nitisinone—Dermatitis exfoliative—Doxorubicin—kidney cancer	0.000742	0.00161	CcSEcCtD
Nitisinone—Agitation—Paclitaxel—kidney cancer	0.000733	0.00159	CcSEcCtD
Nitisinone—Headache—Vinblastine—kidney cancer	0.000729	0.00158	CcSEcCtD
Nitisinone—Headache—Everolimus—kidney cancer	0.000727	0.00158	CcSEcCtD
Nitisinone—Abdominal pain—Dactinomycin—kidney cancer	0.000725	0.00158	CcSEcCtD
Nitisinone—Hypoglycaemia—Doxorubicin—kidney cancer	0.000718	0.00156	CcSEcCtD
Nitisinone—Leukopenia—Paclitaxel—kidney cancer	0.000714	0.00155	CcSEcCtD
Nitisinone—Pruritus—Sorafenib—kidney cancer	0.000712	0.00155	CcSEcCtD
Nitisinone—Eye disorder—Capecitabine—kidney cancer	0.000703	0.00153	CcSEcCtD
Nitisinone—Headache—Erlotinib—kidney cancer	0.000701	0.00152	CcSEcCtD
Nitisinone—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	0.0007	0.00152	CcSEcCtD
Nitisinone—Somnolence—Gemcitabine—kidney cancer	0.000691	0.0015	CcSEcCtD
Nitisinone—Convulsion—Paclitaxel—kidney cancer	0.000691	0.0015	CcSEcCtD
Nitisinone—Diarrhoea—Sorafenib—kidney cancer	0.000689	0.0015	CcSEcCtD
Nitisinone—Pruritus—Sunitinib—kidney cancer	0.000685	0.00149	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000674	0.00146	CcSEcCtD
Nitisinone—Gastrointestinal pain—Vincristine—kidney cancer	0.00067	0.00146	CcSEcCtD
Nitisinone—Alopecia—Capecitabine—kidney cancer	0.000664	0.00144	CcSEcCtD
Nitisinone—Diarrhoea—Sunitinib—kidney cancer	0.000663	0.00144	CcSEcCtD
Nitisinone—Dehydration—Doxorubicin—kidney cancer	0.000651	0.00142	CcSEcCtD
Nitisinone—Abdominal pain—Vincristine—kidney cancer	0.000648	0.00141	CcSEcCtD
Nitisinone—Infection—Paclitaxel—kidney cancer	0.000647	0.0014	CcSEcCtD
Nitisinone—Dry skin—Doxorubicin—kidney cancer	0.000642	0.00139	CcSEcCtD
Nitisinone—Thrombocytopenia—Paclitaxel—kidney cancer	0.000637	0.00138	CcSEcCtD
Nitisinone—Skin disorder—Paclitaxel—kidney cancer	0.000632	0.00137	CcSEcCtD
Nitisinone—Headache—Sorafenib—kidney cancer	0.000631	0.00137	CcSEcCtD
Nitisinone—Diarrhoea—Dactinomycin—kidney cancer	0.000627	0.00136	CcSEcCtD
Nitisinone—Gastritis—Doxorubicin—kidney cancer	0.00062	0.00135	CcSEcCtD
Nitisinone—Headache—Sunitinib—kidney cancer	0.000607	0.00132	CcSEcCtD
Nitisinone—HPD—Metabolism—POMC—kidney cancer	0.000599	0.00203	CbGpPWpGaD
Nitisinone—Leukopenia—Capecitabine—kidney cancer	0.000586	0.00127	CcSEcCtD
Nitisinone—Bronchitis—Doxorubicin—kidney cancer	0.000582	0.00126	CcSEcCtD
Nitisinone—Somnolence—Paclitaxel—kidney cancer	0.000579	0.00126	CcSEcCtD
Nitisinone—Diarrhoea—Vincristine—kidney cancer	0.000561	0.00122	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000553	0.0012	CcSEcCtD
Nitisinone—Pruritus—Gemcitabine—kidney cancer	0.00055	0.00119	CcSEcCtD
Nitisinone—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000532	0.00116	CcSEcCtD
Nitisinone—Diarrhoea—Gemcitabine—kidney cancer	0.000532	0.00116	CcSEcCtD
Nitisinone—Infection—Capecitabine—kidney cancer	0.000531	0.00115	CcSEcCtD
Nitisinone—Conjunctivitis—Doxorubicin—kidney cancer	0.000525	0.00114	CcSEcCtD
Nitisinone—Thrombocytopenia—Capecitabine—kidney cancer	0.000523	0.00114	CcSEcCtD
Nitisinone—Skin disorder—Capecitabine—kidney cancer	0.000519	0.00113	CcSEcCtD
Nitisinone—Abdominal pain—Paclitaxel—kidney cancer	0.000514	0.00112	CcSEcCtD
Nitisinone—Headache—Vincristine—kidney cancer	0.000513	0.00112	CcSEcCtD
Nitisinone—Epistaxis—Doxorubicin—kidney cancer	0.000509	0.00111	CcSEcCtD
Nitisinone—Agranulocytosis—Doxorubicin—kidney cancer	0.000504	0.00109	CcSEcCtD
Nitisinone—Haemoglobin—Doxorubicin—kidney cancer	0.000487	0.00106	CcSEcCtD
Nitisinone—Headache—Gemcitabine—kidney cancer	0.000487	0.00106	CcSEcCtD
Nitisinone—Haemorrhage—Doxorubicin—kidney cancer	0.000485	0.00105	CcSEcCtD
Nitisinone—HPD—Metabolism—PTGS2—kidney cancer	0.000478	0.00162	CbGpPWpGaD
Nitisinone—Pruritus—Paclitaxel—kidney cancer	0.00046	0.001	CcSEcCtD
Nitisinone—Eye disorder—Doxorubicin—kidney cancer	0.000453	0.000984	CcSEcCtD
Nitisinone—Diarrhoea—Paclitaxel—kidney cancer	0.000445	0.000967	CcSEcCtD
Nitisinone—Gastrointestinal pain—Capecitabine—kidney cancer	0.000437	0.000949	CcSEcCtD
Nitisinone—Alopecia—Doxorubicin—kidney cancer	0.000428	0.00093	CcSEcCtD
Nitisinone—Abdominal pain—Capecitabine—kidney cancer	0.000422	0.000917	CcSEcCtD
Nitisinone—HPD—Metabolism—PTEN—kidney cancer	0.000417	0.00141	CbGpPWpGaD
Nitisinone—Tension—Doxorubicin—kidney cancer	0.000414	0.000899	CcSEcCtD
Nitisinone—Nervousness—Doxorubicin—kidney cancer	0.00041	0.00089	CcSEcCtD
Nitisinone—Headache—Paclitaxel—kidney cancer	0.000408	0.000886	CcSEcCtD
Nitisinone—Agitation—Doxorubicin—kidney cancer	0.000388	0.000842	CcSEcCtD
Nitisinone—Pruritus—Capecitabine—kidney cancer	0.000378	0.000821	CcSEcCtD
Nitisinone—Leukopenia—Doxorubicin—kidney cancer	0.000378	0.00082	CcSEcCtD
Nitisinone—Convulsion—Doxorubicin—kidney cancer	0.000365	0.000794	CcSEcCtD
Nitisinone—Diarrhoea—Capecitabine—kidney cancer	0.000365	0.000794	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000357	0.000775	CcSEcCtD
Nitisinone—Infection—Doxorubicin—kidney cancer	0.000342	0.000743	CcSEcCtD
Nitisinone—Thrombocytopenia—Doxorubicin—kidney cancer	0.000337	0.000732	CcSEcCtD
Nitisinone—Headache—Capecitabine—kidney cancer	0.000335	0.000727	CcSEcCtD
Nitisinone—Skin disorder—Doxorubicin—kidney cancer	0.000334	0.000727	CcSEcCtD
Nitisinone—Somnolence—Doxorubicin—kidney cancer	0.000306	0.000665	CcSEcCtD
Nitisinone—HPD—Metabolism—PIK3CA—kidney cancer	0.000294	0.000994	CbGpPWpGaD
Nitisinone—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000282	0.000612	CcSEcCtD
Nitisinone—Abdominal pain—Doxorubicin—kidney cancer	0.000272	0.000591	CcSEcCtD
Nitisinone—Pruritus—Doxorubicin—kidney cancer	0.000244	0.000529	CcSEcCtD
Nitisinone—Diarrhoea—Doxorubicin—kidney cancer	0.000236	0.000512	CcSEcCtD
Nitisinone—Headache—Doxorubicin—kidney cancer	0.000216	0.000469	CcSEcCtD
